Patents Assigned to Universite de Caen Basse Normandie
  • Patent number: 11474099
    Abstract: The invention relates to a novel method for diagnosing the sulfur nutrition state of a plant by measuring the content of certain mineral nutrients in the leaves.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: October 18, 2022
    Assignees: AGRO INNOVATION INTERNATIONAL, UNIVERSITE DE CAEN BASSE NORMANDIE
    Inventors: Elise Sorin, Mustapha Arkoun, Florence Cruz, Jean-Claude Yvin, Anne Maillard, Sylvain Diquelou, Philippe Etienne, Alain Ourry
  • Patent number: 11278609
    Abstract: Medicament for the treatment or the prevention of a bacterial infection, characterized in that it contains at least one polypeptide selected from the group of SEQ ID NO: 1 to SEQ ID NO: 9, and contiguous fragments thereof, wherein said at least one polypeptide or contiguous fragment thereof induces opsonic antibodies in a patient in need thereof. The polypeptides or the contiguous fragments thereof according to the present invention can be used for the preparation of a vaccine against an infection against Enterococcus.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: March 22, 2022
    Assignees: KLINIKUM DER UNIVERSITÄT MÜNCHEN, UNIVERSITE DE CAEN BASSE-NORMANDIE
    Inventors: Johannes Hübner, Axel Hartke, Luis Felipe Romero Saavedra
  • Publication number: 20190339259
    Abstract: The invention relates to a novel method for diagnosing the sulfur nutrition state of a plant by measuring the content of certain mineral nutrients in the leaves.
    Type: Application
    Filed: February 3, 2017
    Publication date: November 7, 2019
    Applicants: Agro Innovation International, Universite de Caen Basse Normandie
    Inventors: Elise SORIN, Mustapha ARKOUN, Florence CRUZ, Jean-Claude YVIN, Anne MAILLARD, Sylvain DIQUELOU, Philippe ETIENNE, Alain OURRY
  • Patent number: 10307410
    Abstract: The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer: Wherein Y1, Y2, Ar1, Ar2, R1, R2, i, j, k, l are as defined in claim 1.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: June 4, 2019
    Assignees: CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE, UNIVERSITE DE CAEN BASSE-NORMANDIE, INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU
    Inventors: Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova-de Oliveira Santos, Ronan Bureau, Grégory Burzicki, Marcella De Giorgi, Serge Perato, Jade Fogha, Sylvain Rault, Philippe Juin, Fabien Gautier
  • Patent number: 10239953
    Abstract: Disclosed herein is a bispecific inhibitor for use in treating thrombotic disorders, such as acute thrombotic disorders like stroke and thromboembolism. The bispecific inhibitor is based on monoclonal antibodies targeting TAFI and PAI-1, and shows efficacy in the presence or the absence of plasminogen activators such as tissue-type plasminogen activator (tPA).
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: March 26, 2019
    Assignees: KATHOLIEKE UNIVERSITEIT LEUVEN, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ DE CAEN BASSE NORMANDIE, CENTRE HOSPITALIER UNVIERSITAIRE DE CAEN
    Inventors: Paul Declerck, Simon De Meyer, Nick Geukens, Ann Gils, Marina Rubio, Denis Vivien, Tine Wyseure
  • Patent number: 10180427
    Abstract: Novel grafted dinuclear metal complexes having formula (I) or of formula (II) wherein M represents a metal ion, and also the use thereof as sensors in a method for detecting and/or characterising cellular microparticles.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: January 15, 2019
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE CAEN BASSE-NORMANDIE, UNIVERSITE GRENOBLE ALPES
    Inventors: Catherine Belle, Gisele Gellon, Laurent Plawinski, Loic Doeuvre, Eduardo Angles Cano
  • Patent number: 9845382
    Abstract: This invention relates to a method for producing functionalized telechelic oligomers, comprising two steps. The first step relates to bringing a raw material comprising at least one high-molecular-weight polymer comprising at least two unsaturations, into contact with a solution comprising at least one metathesis catalyst and at least one functionalizing agent. The second step relates to the separation of the functionalized telechelic oligomers produced by the metathesis reaction in ionic liquid medium of the first step.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: December 19, 2017
    Assignees: Centre National de la Recherche Scientifique, Universite de Caen Basse-Normandie, Universite du Maine
    Inventors: Jean-Francois Pilard, Arnaud Nourry, Isabelle Dez, Annie-Claude Gaumont, Ali Mouawia
  • Patent number: 9732334
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: August 15, 2017
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis Vivien, Jerome Parcq
  • Publication number: 20170071921
    Abstract: The invention relates to compounds of formula (I), and to their therapeutic use in the treatment of cancer: Wherein Y1, Y2, Ar1, Ar2, R1, R2, i, j, k, l are as defined in claim 1.
    Type: Application
    Filed: March 3, 2015
    Publication date: March 16, 2017
    Applicants: CENTRE REGIONAL DE LUTTE CONTRE LE CANCER FRANCOIS BACLESSE, UNIVERSITE DE CAEN BASSE-NORMANDIE, INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU
    Inventors: Laurent POULAIN, Anne-Sophie VOISIN-CHIRET, Jana SOPKOVA-DE OLIVEIRA SANTOS, Ronan BUREAU, Grégory BURZICKI, Marcella DE GIORGI, Serge PERATO, Jade FOGHA, Sylvain RAULT, Philippe JUIN, Fabien GAUTIER
  • Patent number: 9453837
    Abstract: Novel grafted dinuclear metal complexes having formula (I) or of formula (II) wherein M represents a metal ion, and also the use thereof as sensors in a method for detecting and/or characterising cellular microparticles.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 27, 2016
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE DE CAEN BASSE-NORMANDIE, UNIVERSITE JOSEPH FOURIER
    Inventors: Catherine Belle, Gisele Gellon, Laurent Plawinski, Loic Doeuvre, Eduardo Angles Cano
  • Publication number: 20160194623
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Application
    Filed: December 17, 2015
    Publication date: July 7, 2016
    Applicants: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis VIVIEN, Jerome PARCQ
  • Patent number: 9249406
    Abstract: The present invention relates to mutated tissue plasminogen activators, and their use for treating thrombotic diseases.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: February 2, 2016
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Universite de Caen Basse Normandie
    Inventors: Denis Vivien, Jerome Parcq
  • Patent number: 8926736
    Abstract: The present invention relates to reducible porous crystalline solids, constituted of a metal-organic framework (MOF), for the separation of mixtures of molecules having different unsaturation degrees and/or a different number of unsaturations with a selectivity that can be adjusted by controlling the reduction of the MOF. The MOF solids of the present invention, after reduction, have a strong affinity for molecules containing at least one unsaturation. They can be used in various separation processes, especially those relating to hydrocarbons.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: January 6, 2015
    Assignees: Centre National de la Recherche Scientifique -CNRS-, Universite de Caen-Basse Normandie, Universite de Versailles—Saint Quentin en Yvelines, Korea Research Institute of Chemical & Technology (KRICT)
    Inventors: Christian Serre, Alexandre Vimont, Philip Llewellyn, Jong-San Chang, Patricia Horcajada-Cortes, Gérard Ferey, Marco Daturi, Young-Kyu Hwang
  • Patent number: 8541189
    Abstract: The invention relates to a method for measuring the plasmine activity of microparticles, in particular circulating microparticles, in a sample of a biological fluid, particularly a biological fluid in a flow situation, wherein said method can be used as a diagnosis method or a method for following a treatment.
    Type: Grant
    Filed: June 6, 2008
    Date of Patent: September 24, 2013
    Assignees: Institut National de la Sante et de la Recherche Medicale (Inserm), Assistance Publique—Hopitaux de Marseille, Universite d'Aix-Marseille, Universite de caen Basse-Normandie
    Inventors: Eduardo Angles Cano, Romaric Lacroix, Florence Malaterre, Françoise Dignat-George
  • Patent number: 8126140
    Abstract: A method of generating a pseudorandom data sequence, wherein said pseudorandom data sequence is generated by a procedure for searching for a search pattern in an initial data sequence of N bits, said search procedure comprising the following steps: (a) detecting in said initial data sequence a particular search pattern of r bits that is one of a set of search patterns; (b) determining an output pattern of k bits by an operation that depends on the progress of the preceding step; and repeating the preceding steps (a) and (b) successively to form the pseudorandom data sequence from a succession of output patterns.
    Type: Grant
    Filed: August 2, 2004
    Date of Patent: February 28, 2012
    Assignees: France Telecom, Universite de Caen Basse Normandie
    Inventors: Herve Sibert, Aline Gouget
  • Publication number: 20110172412
    Abstract: The present invention relates to reducible porous crystalline solids, constituted of a metal-organic framework (MOF), for the separation of mixtures of molecules having different unsaturation degrees and/or a different number of unsaturations with a selectivity that can be adjusted by controlling the reduction of the MOF. The MOF solids of the present invention, after reduction, have a strong affinity for molecules containing at least one unsaturation. They can be used in various separation processes, especially those relating to hydrocarbons.
    Type: Application
    Filed: June 11, 2009
    Publication date: July 14, 2011
    Applicants: Universite De Caen-Basse Normandie, Centre National De La Recherche Scientifique- CNRS-
    Inventors: Christian Serre, Alexandre Vimont, Philip Llewellyn, Jong-San Chang, Patricia Horcajada-Cortes, Gérard Ferey, Marco Daturi, Young-Kyu Hwang